Pochampally Jalapathi (Jalapathi Pochampally)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Molecular Docking

Breast Cancer Cells

Structure Activity Relationship

Top Venues

Chemistry & biodiversity

RSC medicinal chemistry

Chemistry Central journal

This page only lists publications with an associated author ORCID identifier.

Publications

Shankaraiah Ambala, Thumma Vishnu, Veerabhadraiah Mallikanti, Vineesha Bathini, Jyothi K, Pochampally Jalapathi
Synthesis of New Chroman-4-one Based 1,2,3-Triazole Analogues as Antioxidant and Anti-Inflammatory Agents. Chemistry & biodiversity 21 (7) (2024)
Thumma Vishnu, Veerabhadraiah Mallikanti, Raghavender Matta, Ravinder Dharavath, Pochampally Jalapathi
Design, synthesis, and cytotoxicity of ibuprofen-appended benzoxazole analogues against human breast adenocarcinoma. RSC medicinal chemistry 15 (4) (2024)
Thumma Vishnu, Veerabhadraiah Mallikanti, Raghavender Matta, Ravinder Dharavath, Pochampally Jalapathi
Design, synthesis, and cytotoxicity of ibuprofen-appended benzoxazole analogues against human breast adenocarcinoma. RSC medicinal chemistry 15 (4) (2024)
Shankaraiah Ambala, Thumma Vishnu, Veerabhadraiah Mallikanti, Vineesha Bathini, Jyothi K, Pochampally Jalapathi
Synthesis Of New Chroman-4-one Based 1,2,3-Triazole Analogues As Antioxidant And Anti-inflammatory Agents. Chemistry & biodiversity (2024)
Shankaraiah Ambala, Thumma Vishnu, Veerabhadraiah Mallikanti, Vineesha Bathini, Jyothi K, Pochampally Jalapathi
Synthesis of New Chroman-4-one Based 1,2,3-Triazole Analogues as Antioxidant and Anti-Inflammatory Agents. Chemistry & biodiversity 21 (7) (2024)
Bhookya Shankar, Pochampally Jalapathi, Balabadra Saikrishna, Shaym Perugu, Vijjulatha Manga
Synthesis, anti-microbial activity, cytotoxicity of some novel substituted (5-(3-(1H-benzo[d]imidazol-2-yl)-4-hydroxybenzyl)benzofuran-2-yl)(phenyl)methanone analogs. Chemistry Central journal 12 (1) (2018)